Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Azacytidine and Romidepsin in R/R PTCL
NCT04747236Phase 2Recruiting
- Sponsor
- University of Virginia
- Start
- Feb 2021
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of azacitidine in peripheral T-cell lymphoma (PTCL), sponsored by University of Virginia. Started Feb 2021; status: recruiting.
02
Drugs
azacitidine
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT04747236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04747236.